CD4 and neoplasm: NLRP3 inflammasome activation can also promote intestinal epithelial cells to secrete IL-18, exerting an anti-tumor effect on immune cells such as CD4+ T cells (in AOM-induced colorectal cancer) (Du et al., 2016).